Castagnetto Michael D.

President Michael D. Castagnetto buys 594 shares of CHRW at $168.24; cluster pattern with 3 other insiders buying in past 14 days

Michael D. Castagnetto, President of C. H. ROBINSON WORLDWIDE, purchased 594 shares at $168.24 on 2026-02-12, bringing his holdings to 35,488 shares (+1.7% net change). The transaction occurs within a cluster buy pattern, with 3 other insiders also purchasing shares within the past 14 days. At the current price of $176.01, the stock is -12.2% from its 52-week high but +2.2% over 30 days and +15.2% over 90 days. However, Castagnetto's prior trades at CHRW show a mixed timing pattern: his 2 prior sales on 2025-11-03 were followed by positive 90-day returns (+28.7% and +28.3% respectively), indicating those sells were not well-timed as he sold before subsequent gains. The company's fundamentals show $4.1B in latest quarterly revenue and $163.0M net income, though annual revenue growth stands at -8.4% with a P/E of 28.95. The coincident buying activity across multiple insiders may warrant investor attention as a potential signal, though individual timing history at this ticker suggests prior trades lacked precision.

CHRW President Castagnetto sells 45.3K shares across 2 transactions for $6.9M at blended $151.70; reduces holdings 57.6% to 33.4K shares

Michael D. Castagnetto, President of C. H. Robinson Worldwide, executed 2 separate sales on November 3, 2025, totaling 45,266 shares for $6,866,685.72 at prices of $151.48 and $152.00, reducing his holdings from 78,654 shares to 33,388 shares—a net reduction of 57.6%. The sale occurred near the stock's 52-week high of $154.88 and follows strong recent momentum (30-day change: +14.0%, 90-day change: +30.0%), with the current price at $153.13 representing a modest -1.1% discount to the 52-week high. The magnitude of this disposition—eliminating more than half of his pre-transaction stake in a single filing—stands as a material reduction in insider exposure to the company, particularly notable given the stock's elevated valuation (P/E: 30.14) and muted growth backdrop (annual revenue growth +0.7%).